Agenda Details

Learn more about sessions and presentations at the 26th Annual Meeting

Detailed Program

Tuesday, May 16 2023
10:40 AM – 11:10 AM PT

Market Approved Therapies- Focus on ex vivo Lenti Gene Therapy to Cover Other Technologies

Jasmine Greenamyer. Bristol Myers Squibb, DC

Disclosures: J. Greenamyer: None.

© 2000-2023 All rights reserved. American Society of Gene & Cell Therapy. 

Kentico CMS Development by Reason One | Powered by Kentico

This site uses cookies to offer you a better user experience and to analyze site traffic. By continuing to use this website, you accept our use of cookies.